NASDAQ:BIAF bioAffinity Technologies - BIAF News Today Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding bioAffinity Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $2.87 -0.19 (-6.20%) (As of 01/27/2023 12:00 AM ET) Add Compare Share Share Today's Range$2.70▼$3.2450-Day Range$1.52▼$3.0652-Week Range$1.31▼$15.55Volume838,356 shsAverage Volume3.88 million shsMarket Capitalization$7.84 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesSEC FilingsSocial Media Get bioAffinity Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for BIAF and its competitors with MarketBeat's FREE daily newsletter. Email Address BIAF Media Mentions By Week BIAF Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BIAF News Sentiment▼0.130.70▲Average Medical News Sentiment BIAF News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BIAF Articles This Week▼41▲BIAF Articles Average Week All Sources Trusted Sources MarketBeat.com Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineU.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.31%msn.com - January 24 at 6:49 PMBIAF bioAffinity Technologies, Inc.seekingalpha.com - January 24 at 8:48 AMbioAffinity Technologies Announces Publication of Results of Clinical Trial in Peer-Reviewed Journal Respiratory Researchfinance.yahoo.com - January 24 at 8:48 AMbioAffinity Technologies Announces Notice to Award U.S. Patent Protecting Novel Compounds for Specific Delivery of Cancer Treatmentsfinance.yahoo.com - January 4 at 9:09 AMArgus Research Initiates Equity Research Report Coverage on bioAffinity Technologies, Inc. (NasdaqCM: BIAF)finance.yahoo.com - December 19 at 12:43 PMbioAffinity Technologies Expands Diagnostic Division with Promotions and New Hires to Strengthen Clinical Benchfinance.yahoo.com - December 15 at 1:28 PMbioAffinity Technologies to Report Third Quarter 2022 Financial Resultsfinance.yahoo.com - November 8 at 11:50 AMSan Antonio cancer biotech follows IPO with patent win in Chinabizjournals.com - November 2 at 2:47 PMbioAffinity Technologies Inc.wsj.com - October 13 at 4:23 AMBehind the Deal: Company’s decision to go public drawing capital and attention to SAbizjournals.com - September 30 at 11:20 AMNasdaq Surges Over 150 Points; Gold Rises 2%markets.businessinsider.com - September 29 at 10:22 AMWhy BioAffinity Technologies Shares Are Skyrocketingmsn.com - September 14 at 4:16 PMBioAffinity Publishes Peer Resultsbaystreet.ca - September 14 at 11:15 AMBioAffinity Technologies Shares Spikenasdaq.com - September 14 at 11:15 AMbioAffinity Technologies Inc (BIAF)investing.com - September 10 at 5:09 AMSan Antonio biotech goes public raising nearly $8Mbizjournals.com - September 9 at 6:59 PMbioAffinity Technologies Increuters.com - September 6 at 8:28 PMbioAffinity Technologies, Inc. Announces Closing of $7.8 Million Initial Public Offeringfinance.yahoo.com - September 6 at 3:27 PMWallachBeth Capital Announces Closing Of bioAffinity Technologies, Inc. $7.8 Million Initial Public Offeringfinance.yahoo.com - September 6 at 3:27 PMbioAffinity Technologies, Inc. (BIAF)ca.finance.yahoo.com - September 2 at 9:54 PMbioAffinity Technologies IPO Opens Sharply Higherinvesting.com - September 2 at 11:54 AMLung cancer test developer bioAffinity prices $8M IPOseekingalpha.com - September 2 at 11:54 AMBioAffinity stock soars over 150% following $8M IPOseekingalpha.com - September 2 at 11:54 AM Get bioAffinity Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for BIAF and its competitors with MarketBeat's FREE daily newsletter. Email Address This page (NASDAQ:BIAF) was last updated on 1/28/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.